Liu, Y. and Luo, Y. (2026) A Corpus-Based Study of Musicality in Zhu Shenghao’s Translation of Shakespeare’s Four Great Tragedies. Open Journal of Social Sciences, 14, 425-438. doi: ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA. The British drugmaker had been ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced positive results from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, evaluating the ...
Please provide your email address to receive an email when new articles are posted on . Clascoterone 5% topical solution targets the androgen receptor in the hair follicle without measurable systemic ...
EAST STROUDSBURG, Pa. — Traffic is flowing on Interstate 80 in East Stroudsburg near exit 308. The construction is part of the Interstate 80 Expansion Project. Work started in April of 2022. PennDOT ...
The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of Aleta’s first-in-class biologic CAR T-cell engager, ALETA-001 Preliminary findings include a ...
The European Union agreed Wednesday to phase out Russian natural gas imports by late 2027 as part of an effort to end the bloc’s decade-long dependency on Russian energy. Representatives for EU ...
Veradermics Advances VDPHL01 in Phase 2/3 Clinical Trial for Female Pattern Hair Loss, Marking a Milestone in the Development of the Potential First-Ever Oral Prescription Treatment for Women VDPHL01 ...
The MarketWatch News Department was not involved in the creation of this content. MELBOURNE, Australia, Nov. 14, 2025 /PRNewswire/ -- Samson Clinical (Samson), an Australian pharmaceutical company ...
Israel does not intend to allow Hamas to “drag out” the process of returning the bodies of the fallen. No negotiations will begin on phase B of US President Donald Trump’s plan until Hamas returns all ...
Metsera, Inc. (NASDAQ:MTSR) on Tuesday released topline data from VESPER-1 and data from a planned interim analysis for tolerability of VESPER-3 – two Phase 2b trials of MET-097i with potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results